Cardium Therapeutics, Inc. Reports On Third Quarter 2013 Financial Results And Recent Business Developments

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

SAN DIEGO, Nov. 19, 2013 /PRNewswire/ -- Cardium Therapeutics (NYSE MKT: CXM) today presented its financial results for the third quarter ended September 30, 2013, and reported on recent highlights and other business developments including:

-- Sale of To Go Brands(R) business to Cell-nique Corporation and Healthy Brands Collective(R) in an asset purchase for approximately $2.5 million through the exchange of a preferred equity position in Healthy Brands.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC